UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000036455
Receipt No. R000041544
Scientific Title Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma
Date of disclosure of the study information 2019/04/10
Last modified on 2019/04/09 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma
Acronym Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma
Scientific Title Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma
Scientific Title:Acronym Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma
Region
Japan

Condition
Condition Hepatocellular carcinoma
Classification by specialty
Hepato-biliary-pancreatic medicine Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the clinical outcomes and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Overall survival rate
Local control rate
Cost effectiveness
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria Patients with localized HCC treated with C-ion RT or TACE.
Key exclusion criteria The patient with: 1) direct infiltration of the gastrointestinal tract; 2) intrahepatic metastasis; 3) distant metastasis, and; 4) major vascular invasion were excluded.
Target sample size 60

Research contact person
Last name of lead principal investigator
1st name Kei
Middle name
Last name Shibuya
Organization Gunma University Graduate School of Medicine
Division name Department of Radiation Oncology
Zip code 371-8511
Address 3-39-22, Syowa-machi, Maebashi, Gunma
TEL 027-220-8383
Email shibukei@gunma-u.ac.jp

Public contact
1st name of contact person
1st name Shintaro
Middle name
Last name Shiba
Organization Gunma University Graduate School of Medicine
Division name Department of Radiation Oncology
Zip code 371-8511
Address 3-39-22, Syowa-machi, Maebashi, Gunma
TEL 027-220-8383
Homepage URL
Email shiba4885@yahoo.co.jp

Sponsor
Institute Department of Radiation Oncology, Gunma University Graduate School of Medicine
Institute
Department

Funding Source
Organization Department of Radiation Oncology, Gunma University Graduate School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Gunma University Hospital Institutional Review Board
Address 3-39-15, Syowa-machi, Maebashi, Gunma
Tel 027-220-8740
Email gunma-ciru@ml.gunma-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 04 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 54
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2019 Year 03 Month 22 Day
Date of IRB
2019 Year 03 Month 22 Day
Anticipated trial start date
2019 Year 03 Month 22 Day
Last follow-up date
2021 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Retrospective analysis

Management information
Registered date
2019 Year 04 Month 09 Day
Last modified on
2019 Year 04 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041544